Nature Cancer:让癌细胞“一睡不醒”!向肿瘤微环境中添加III型胶原蛋白可防止肿瘤复发和转移

2022-01-03 生物探索 网络

近日,来自美国西奈山伊坎医学院的研究团队突发奇想:将肿瘤细胞永久地停留在休眠期(即细胞周期停滞于G0/G1期),一直“沉睡”下去!该研究近期发表于Nature Cancer,阐释了肿瘤微环境中的细胞外

一听到“肿瘤”二字,大家都会不寒而栗,如果再听到“肿瘤转移”,那么就更是雪上加霜了。如果我们能将“肿瘤转移”扼杀在摇篮中,是不是就有望将肿瘤患者从死亡悬崖上拉回来?

近日,来自美国西奈山伊坎医学院的研究团队突发奇想:将肿瘤细胞永久地停留在休眠期(即细胞周期停滞于G0/G1期),一直“沉睡”下去!该研究近期发表于Nature Cancer,阐释了肿瘤微环境中的细胞外基质对肿瘤细胞进入和维持休眠状态的关键作用。

研究成果(图源:Nature Cancer)

首先,研究者们从休眠肿瘤细胞的“根据地”——胶原细胞外基质(ECM) 的三维结构组织着手。为此,他们将休眠型肿瘤细胞系和增殖型肿瘤细胞系通过尾静脉注射的方式接种到小鼠体内,不像增殖型肿瘤细胞在小鼠体内迅速形成肿瘤,休眠型肿瘤细胞在小鼠体内通常是以单个细胞或惰性小结节的形式存在。

在多光子二次谐波成像下,研究结果显示,休眠细胞周围的胶原纤维具有非线性排列和波状结构的特征,并在癌细胞再活化过程中能够转换到高度的线性状态。

休眠型肿瘤细胞与增殖型肿瘤细胞(图源:Nature Cancer)

由于休眠性和增殖性肿瘤的ECM在结构上是不同的,因此研究者们试图通过对脱细胞化的增殖期肿瘤和处于休眠期的肿瘤进行质谱分析从而确定它们的组成或“基质体”是否不同。结果表明:休眠细胞在体内形成小结节,而增殖期肿瘤在体内形成生长中的肿瘤团块。这一差异分析显示,休眠癌细胞的基质体高度富含胶原蛋白且占比55%(其中胶原蛋白I、III、V和VI型的丰度更高),而在增殖性肿瘤中仅占基质体的36%。

T-HEp3(增殖期肿瘤)和D-HEp3(休眠期肿瘤)的胶原蛋白类型对比(图源:Nature Cancer)

接着,研究者使用人-小鼠异种移植系统进一步确定肿瘤细胞(人类蛋白序列)和基质细胞(小鼠蛋白序列)对基质体生产的相对贡献。检测显示,与增殖细胞相比,III型胶原蛋白在休眠肿瘤细胞中最丰富。

各型胶原蛋白密度对比(图源:Nature Cancer)

II型胶原蛋白的生物工程支架治疗局部残留的癌细胞(原发肿瘤切除后观察到的)是否可以防止残留的休眠癌细胞被唤醒呢?为此,研究使用了表达CDK2生物传感器的T-HEp3细胞,最后结果显示,只有20%的含支架III型胶原蛋白治疗的小鼠在肿瘤手术后复发,而对照组中80%的肿瘤复发。

 

 术后肿瘤局部复发情况(图源:Nature Cancer)

由于III型胶原蛋白丰度的增加与COL3A1(癌细胞处于休眠期间运行的基因网络的一部分)在mRNA水平和蛋白水平上的高表达相关。为了确定COL3A1在维持癌细胞休眠中的作用,研究者们使用siRNA敲除了休眠D-HEp3细胞中的COL3A1并进行了体内生长实验。有趣的是,在休眠细胞中过表达的其他胶原链对肿瘤休眠没有明显的影响。而D-HEp3中COL3A1的缺失会导致休眠诱导基因NR2F1的表达显著降低。这些结果首次揭示了COL3A1在诱导和维持休眠中的作用。也就是说,III型胶原蛋白不但抑制肿瘤增殖、诱导肿瘤细胞进入休眠状态,同时也是肿瘤细胞维持休眠状态的关键。

最后,研究人员发现了存在于III型胶原蛋白和休眠肿瘤细胞之间的正反馈通路:III型胶原蛋白与肿瘤细胞DDR1受体结合,激活STAT1(DDR1下游潜在的调控休眠的转录因子)入核促进COL3A1表达,然后肿瘤细胞分泌III型胶原蛋白,进而将肿瘤细胞维持在休眠状态。

III型胶原蛋白和休眠肿瘤细胞之间的正反馈通路(图源:Nature Cancer)

总的来说,本研究描述了一种新的细胞休眠机制:向肿瘤微环境中添加III型胶原蛋白,能够促进肿瘤细胞进入并维持在休眠状态,抑制肿瘤增殖。让我们期待在不久的将来临床上可以利用III型胶原蛋白作为检测肿瘤复发的标志物以预防肿瘤的复发和转移。

参考资料:

[1]Di Martino, J.S., Nobre, A.R., Mondal, C. et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer (2021). https://doi.org/10.1038/s43018-021-00291-9

[2]Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014 Sep;14(9):611-22. doi: 10.1038/nrc3793. Epub 2014 Aug 14. PMID: 25118602; PMCID: PMC4230700.

[3]肿瘤新突破!Nature Cancer: 这种胶原蛋白,能让肿瘤细胞进入休眠!https://mp.weixin.qq.com/s/ihmuc7vJKeYNVku_ENX7ow

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-04-14 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-04-08 juliusluan78
  4. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-09 ms8000001465072660

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-09 147c84a3m71暂无昵称

    good

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-07 yxch36
  7. [GetPortalCommentsPageByObjectIdResponse(id=1885587, encodeId=a862188558e95, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Apr 14 09:09:25 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705606, encodeId=b5331e0560663, content=<a href='/topic/show?id=0f5a8288537' target=_blank style='color:#2F92EE;'>#肿瘤复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82885, encryptionId=0f5a8288537, topicName=肿瘤复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a4e30995147, createdName=AspirantSuo, createdTime=Sat May 07 23:09:25 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916511, encodeId=dda519165113c, content=<a href='/topic/show?id=c5a89550ff' target=_blank style='color:#2F92EE;'>#III#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9550, encryptionId=c5a89550ff, topicName=III)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Fri Apr 08 16:09:25 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182472, encodeId=a4b511824e24f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcbc6454654, createdName=ms8000001465072660, createdTime=Sun Jan 09 11:16:12 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182462, encodeId=f41a118246278, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f5243924, createdName=147c84a3m71暂无昵称, createdTime=Sun Jan 09 10:40:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252810, encodeId=a4681252810ab, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485729, encodeId=4bac1485e29a0, content=<a href='/topic/show?id=8f0c840392a' target=_blank style='color:#2F92EE;'>#胶原蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84039, encryptionId=8f0c840392a, topicName=胶原蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11fc8038511, createdName=12498e5fm14(暂无昵称), createdTime=Fri Jan 07 02:09:25 CST 2022, time=2022-01-07, status=1, ipAttribution=)]

相关资讯

Seminars in Cancer Biology:肠道微生物有助于抗癌免疫调节

肠道微生物区系在影响肿瘤发生和癌细胞对治疗药物的反应方面具有重要作用。微生物区系对癌症的显著影响推动了操纵微生物区系来预防和治疗癌症的努力。微生物操作可以作为传统癌症治疗的辅助手段。

如何重塑肿瘤微环境,强化抗PD-1疗效?Treg细胞的Blimp1表达是关键!

该研究揭示了Blimp1是一种肿瘤浸润性Treg细胞新的关键调控因子,以及通过调节Treg活性来治疗肿瘤的潜力。

Nat Commun:细胞外基质和适应性粘附动力学共同驱动卵巢癌的化疗抗性

肿瘤微环境(TME)中的细胞外基质(ECM)衍生的生化和生物力学因素对癌细胞的转移和治疗抗性至关重要。

Nat Commun:恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境

恶性胸膜间皮瘤(MPM)是一种罕见的、无法治愈的癌症。

Dev Cell:周俊等解析肿瘤微环境对肿瘤生长的影响

2021年6月30日,德国癌症研究中心和海德堡大学 Michael Boutros 课题组在 Developmental Cell 期刊在线发表了题为:Microenvironmental innat

Nat Commun:脑脊液的免疫细胞分析可表征脑转移瘤微环境

脑转移瘤(BrM)是脑部中最常见的肿瘤,是一种破坏性的癌症并发症。